The DOI matches its Crossref record; 340 of the 340 references it cites were found in a registry or an index.
Nosocomial fungal infections: epidemiology, diagnosis, and treatment
Abstract
Invasive fungal infections are increasingly common in the nosocomial setting. Furthermore, because risk factors for these infections continue to increase in frequency, it is likely that nosocomial fungal infections will continue to increase in frequency in the coming decades. The predominant nosocomial fungal pathogens include Candida spp., Aspergillus spp., Mucorales, Fusarium spp., and other molds, including Scedosporium spp. These infections are difficult to diagnose and cause high morbidity and mortality despite antifungal therapy. Early initiation of effective antifungal therapy and reversal of underlying host defects remain the cornerstones of treatment for nosocomial fungal infections. In recent years, new antifungal agents have become available, resulting in a change in standard of care for many of these infections. Nevertheless, the mortality of nosocomial fungal infections remains high, and new therapeutic and preventative strategies are needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“C. albicans is still the most prevalent cause of Candida infections worldwide (53).”
From Mitochondrial Cochaperone Mge1 Is Involved in Regulating Susceptibility to Fluconazole in Saccharomyces cerevisiae and Candida Species (2017) · cites this paper as [53]
In the citing paper
“C. glabrata and C. albicans are two of the most frequently isolated pathogenic fungi in humans (53).”
From Mitochondrial Cochaperone Mge1 Is Involved in Regulating Susceptibility to Fluconazole in Saccharomyces cerevisiae and Candida Species (2017) · cites this paper as [53]
In the citing paper
“This is because chelators such as deferoxamine have bacterial origins as siderophores and can be used by certain microorganisms, such as Rhizopus spp. in the case of mucormycosis, and Salmonella typhimurium in the case of salmonellosis (Perloth et al., 2007).”
From Iron at the Centre of Candida albicans Interactions (2018) · cites this paper as Perloth et al., 2007
In the citing paper
“One of these is Candida glabrata, an opportunistic fungal pathogen that colonizes epithelial surfaces like the gastrointestinal tract as part of the normal human microbiota (5).”
From A novel hybrid iron regulation network combines features from pathogenic and nonpathogenic yeasts (2016) · cites this paper as [5]
In the citing paper
“These species include C. dubliniensis, C. tropicalis, C. parapsilosis, C. guillermondii, C. krusei, and C. glabrata (80, 90, 118, 151).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [151]
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Bone marrow transplant: Angela Joyce on the care of children undergoing BMT for genetic disorders
Joyce, A. (1989) · Paediatric Nursing · doi:10.7748/paed.1.6.21.s21 · Cited by 3,384
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
Roden, M. M., Zaoutis, T. E., Buchanan, W. L., Knudsen, T. A., Sarkisova, T. A., Schaufele, R. L., Sein, M., Sein, T., Chiou, C. C., Chu, J. H., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/432579 · Cited by 3,044
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331
Ribes, J. A., Vanover-Sams, C. L., & Baker, D. J. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.2.236 · Cited by 1,711
Novel perspectives on mucormycosis: pathophysiology, presentation, and management
Spellberg, B., Edwards, J., & Ibrahim, A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.3.556-569.2005 · Cited by 1,537
Self-citation
Research works printed but not linked: 18
- Kullberg BJ, 2002, Eur J Med Res, 7, 183
- Bross J, 1989, Am J Med, 87, 614, 10.1016/s0002-9343(89)80392-4 · doi:10.1016/s0002-9343(89)80392-4 · Paper page
- Lehrer N, 1983, Ann Microbiol (Paris), 134, 293
- Snelling CF, 1978, Can Med Assoc J, 119, 466
- Hung CC, 1996, J Formos Med Assoc, 95, 19
- Pappo I, 1994, Nutrition, 10, 151
- Gaines JD, 1972, Surgery, 72, 730
- Verghese S, 1998, Indian Heart J, 50, 418
- Ziege SU, 2000, Eur J Med Res, 5, 369
- Ruhnke M, 2005, Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
- Arnow PM, 1978, Am Rev Respir Dis, 118, 49
- Torres HA, Lancet Infect Dis, 2005, 775
- Ribes JA, 2000, Clin Microbiol Rev, 13, 236, 10.1128/cmr.13.2.236-301.2000 · doi:10.1128/cmr.13.2.236-301.2000 · Paper page
- AS Ibrahim, J. E. J. Edwards, S. G. Filler, WE Dismukes, PG Pappas, and JD Sobel ,Zygomycosis . In:Clinical mycology. and.2003 .Oxford University Press. p.241 –251 .
- Kontoyiannis DP, 1990, Clin Infect Dis, 2000, 851
- Morrison VA, 1993, Bone Marrow Transplant, 11, 383
- Nithyanandam S, 2003, Indian J Ophthalmol, 51, 231
- Khor BS, 2003, J Microbiol Immunol Infect, 36, 266
Cited by
Candida albicans pathogenicity mechanisms
Mayer, F. L., Wilson, D., & Hube, B. (2013) · Virulence · doi:10.4161/viru.22913 · Cited by 1,848
“In stark contrast, systemic candidiasis is associated with a high crude mortality rate, even with first line antifungal therapy.(3,4,12) Both neutropenia and damage of the gastrointestinal mucosa are risk factors for the development of experimental systemic (disseminated) candidiasis.”
BackgroundEpidemiology and Clinical Manifestations of Mucormycosis
Petrikkos, G., Skiada, A., Lortholary, O., Roilides, E., Walsh, T. J., & Kontoyiannis, D. P. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir866 · Cited by 1,452
Candida albicans Biofilms and Human Disease
Nobile, C. J., & Johnson, A. D. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104330 · Cited by 1,057
Pierce, C. G., Uppuluri, P., Tristan, A. R., Wormley, F. L., Mowat, E., Ramage, G., & Lopez-Ribot, J. L. (2008) · Nature Protocols · doi:10.1038/nprot.2008.141 · Cited by 1,041
“Fungi, being eukaryotic cells and more complex than bacteria, cause infections that are often difficult to diagnose and treat, and carry unacceptably high mortality rate”
BackgroundEpidemiology of Invasive Mycoses in North America
Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901
“These data include not only candidemia but also other forms of invasive candidiasis that may not be associated with positive blood cultures, which may explain why the estimates are higher than several population-based studies, of candidemia incidence (Table 8) (Perlroth et al. 2007).”
BackgroundResultInfluential
Metadata
- Authors
- Perlroth, J., Choi, B., & Spellberg, B.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Spellberg, Brad
- Venue
- Medical Mycology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-01
- Volume
- 45
- Issue
- 4
- Pages
- 321-346
- ISSN
- 0268-1218 (ISSN-L)
- 1369-3786
- 1460-2709
- OpenAlex
- W2135840745
- Cited by
- 738
- References
- 337
- Citations by year
- 2026: 8 · 2025: 25 · 2024: 42 · 2023: 24 · 2022: 55 · 2021: 49 · 2020: 60 · 2019: 56 · 2018: 42 · 2017: 54 · 2016: 43 · 2015: 49 · 2014: 41 · 2013: 31 · 2012: 30
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Medical Mycology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (K08AI060641)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Keywords
- nosocomial fungal infections, invasive fungal infections, Candida, Aspergillus, Mucorales, Fusarium, Scedosporium, antifungal therapy, antifungal agents, fungal infection diagnosis, epidemiology, mortality, risk factors, nosocomial infections
- MeSH terms
- Antifungal Agents, Aspergillosis, Candidiasis, Cross Infection, Drug Therapy, Combination, Humans, Mucormycosis, Mycoses, Risk Factors, Global Health, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nosocomial fungal infections: epidemiology, diagnosis, and treatment. https://app.cochat.ai/papers/10.1080/13693780701218689
- The paper
- Perlroth, J., Choi, B., & Spellberg, B. (2007). Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Medical Mycology. https://doi.org/10.1080/13693780701218689
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.